Abhijeet Kumar, MD

Description

I focus on being highly accessible and responsive for each of my patients.

Keywords multiple myeloma with bone involvement, de-escalation treatment, neoadjuvant treatment, neurotrophic tyrosine receptor kinase gene fusion, inherited hematologic malignancies, complement mediated hemolytic uremic syndrome, decreased hemoglobin, iron replacement, iron level, iron binding capacity, ferritin, cardiolipin antibody assay, hypersplenism, acquired factor inhibitor, monoclonal paraproteinemia, prolonged partial thromboplastin time, prolonged prothrombin time, neutrophilia, monoclonal b-cell lymphocytosis, macrocytosis, elevated hemoglobin, elevated transferrin saturation, elevated ferritin, high iron, autoimmune (aa) amyloidosis, light chain (al) amyloidosis, thrombotic microangiopathy, paraprotein associated cryoglobulinemia, monoclonal gammopathy of renal significance, abnormal protein, iron infusion therapy, bone marrow aspiration, disseminated intravascular coagulation, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, leukocytosis, white blood cell disorders, red blood cell disorders, plasma cell and antibody production disorders, iron metabolism disorders, cold agglutinin disease, coagulation disorders, bone marrow failure syndromes, autoimmune hemolytic anemia, hemoglobinopathies, thrombocytosis, aplastic anemia, castleman's disease, blood disorders, lymphopenia, von willebrand disease, poems syndrome, anemia of chronic disease, pernicious anemia, hemolytic anemia, bone marrow disorders, adverse effects to anticoagulants, fanconi anemia, thrombotic thrombocytopenic purpura, thrombophilia, thrombocytopenia, thalassemia, splenomegaly, secondary polycythemia, sarcoma, polycythemia, petechiae, pancytopenia, lupus anticoagulant, iron deficiency anemia, idiopathic thrombocytopenic purpura, hypercoagulable state, heparin induced thrombocytopenia, hemochromatosis, hellp syndrome, graft versus host disease, factor eight disorder, deep vein thrombosis, deep thrombophlebitis, catastrophic antiphospholipid syndrome (caps), platelet disorder, blood clotting disorder, blood clot, bleeding disorder, b12 deficiency anemia, antiphospholipid syndrome, anticoagulation, anemia, primary systemic amyloidosis, hydroxyurea therapy, adjuvant chemotherapy, plasmablastic lymphoma, follicular t-cell lymphoma, b cell lymphoproliferative disorder, solitary plasmacytoma, metastatic blood cancers, human t-cell lymphotropic virus type 1, human t-cell lymphotropic virus type 2.